EUVIMEDEUVIMED entdecken
Crossref

Budesonide and Surfactant Combination for Treatment of Respiratory Distress Syndrome in Preterm Neonates and Evaluation Outcomes

Fatemeh Baghal Safa, Mahmood Noorishadkam, Mohamad Hosein Lookzadeh, Seyed Reza Mirjalili, Sedigheh Ekraminasab

Journal of Clinical Neonatology · 2023-10 · 12 (4) · 135-141

DOI: 10.4103/jcn.jcn_52_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Neonatology, online erschienen am 21.12.2023. Verfasst von Fatemeh Baghal Safa und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary inflammation plays a critical role in the pathogenesis of respiratory distress syndrome. The aim of this study was to compare the effectiveness of intratracheal administration combination of pulmonary surfactant (PS) and budesonide with surfactant alone in preterm neonates. Materials and Methods: This randomized clinical trial was performed in Yazd between 2020 and 2022. A total of 70 preterm neonates weighing between 800 and 1500 g were included in the study.

Results

The risk of bronchopulmonary dysplasia (BPD) in infants treated with PS and budesonide was seven times lower than in the surfactant group alone ( P = 0.004). Furthermore, in the intervention group, the hospitalization period ( P = 0.004) and retinopathy of prematurity ( P = 0.02) were significantly reduced.

Conclusion

In these neonates, intratracheal administration of surfactant/budesonide combination significantly decreases the incidence of frequent apnea, BPD, continuous positive airway pressure therapy, and earlier discharge. There is a need for larger trials and an exact evaluation of side effects.

Zitieren

APA

Safa, F. B., Noorishadkam, M., Lookzadeh, M. H., Mirjalili, S. R., & Ekraminasab, S. (2023). Budesonide and Surfactant Combination for Treatment of Respiratory Distress Syndrome in Preterm Neonates and Evaluation Outcomes. Journal of Clinical Neonatology, 12(4), 135-141. https://doi.org/10.4103/jcn.jcn_52_23

Vancouver

Safa FB, Noorishadkam M, Lookzadeh MH, Mirjalili SR, Ekraminasab S. Budesonide and Surfactant Combination for Treatment of Respiratory Distress Syndrome in Preterm Neonates and Evaluation Outcomes. Journal of Clinical Neonatology. 2023;12(4):135-141. doi:10.4103/jcn.jcn_52_23

BibTeX
@article{Safa2023,
  author = {Safa, Fatemeh Baghal and Noorishadkam, Mahmood and Lookzadeh, Mohamad Hosein and Mirjalili, Seyed Reza and Ekraminasab, Sedigheh},
  title = {Budesonide and Surfactant Combination for Treatment of Respiratory Distress Syndrome in Preterm Neonates and Evaluation Outcomes},
  journal = {Journal of Clinical Neonatology},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {135--141},
  doi = {10.4103/jcn.jcn_52_23}
}
Kostenlos starten →